Siemens adds ARK Fentanyl Assay to its testing menu

Create PDF

Jan. 27, 2020—Siemens Healthineers has added the ARK Fentanyl Assay to its testing menu.

The ARK Fentanyl Assay, from ARK Diagnostics, can detect norfentanyl and the parent fentanyl, enabling laboratories to identify more true positives. The assay “extends the detection window to provide the information clinicians need to triage their patients more appropriately,” the company said in a press release. Assays measuring solely the parent fentanyl typically have a shorter window for detection.